Mediators of inflammation in the early and the late phase of allergic rhinitis

Current Opinion in Allergy and Clinical Immunology

Volumn 4, Issue 3, 2004, Pages 159-163

  Hansen, Inga ^a,b   Klimek, Ludger ^b,d   Mösges, Ralph ^c   Hörmann, Karl ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Center for Rhinology and Allergology   (Germany)

^c IMSIE   (Germany)

^d NONE   (Germany)

Author keywords

Allergic rhinitis; Cytokine; Early phase reaction; Inflammation; Late phase reaction; Mediator

Indexed keywords

BETA CHEMOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 3; INTERLEUKIN 6; NERVE GROWTH FACTOR; NITRIC OXIDE SYNTHASE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; VASCULOTROPIN A;

ALLERGIC RHINITIS; CELL ACTIVATION; CHEMOTAXIS; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG TARGETING; EXTRACELLULAR MATRIX; HUMAN; LACRIMATION; MEDIATOR RELEASE; NONHUMAN; NOSE CONGESTION; NOSE MUCUS; PRIORITY JOURNAL; PRURITUS; REVIEW; RHINORRHEA; SNEEZING; TRANSGENIC MOUSE;

CYTOKINES; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; INTERLEUKIN-3; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTES; NERVE GROWTH FACTOR; NITRIC OXIDE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 2542490249     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200406000-00004     Document Type: Review

References (52)

1. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001; 108:143.
2. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998; 81:478-518.
3. Naclerio RM. Allergic rhinitis. N Engl J Med 1991; 325:860-869.
4. Turner H, Kinet JP. Signaling through the high-affinity IgE receptor Fc epsilon R1. Nature 1999; 25:B24-B30.
5. Williams CM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000; 105:847-859.
6. Grant JA, Huamin L. Biology of basophils. In: Middleton EJ, Reed CE, Ellis EF, et al, editors. Allergy: principles and practice. St Louis, MO: Mosby; 1998. pp. 277-284.
7. Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313:65-70.
8. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge: effect of systemic steroid pretreatment. Am Rev Respir Dis 1988; 138:406-412.
9. Kita H, Adolphson CR, Gleich GJ. Biology of eosinophils. In: Middleton EJ, Reed CE, Ellis EF, et al., editors. Allergy: principles and practice. St Louis, MO: Mosby; 1998: 242-260.
10. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390-2394.
11. Clutterbuck EJ, Hirst EM, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 1989; 73:1504-1512.
12. Palframan RT, Collins PD, Severs NJ, et al. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med 1998; 9:1621-1632.
13. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338:1592-1600.
14. Broide DH, Humber D, Sullivan S, Sriramarao P. Inhibition of eosinophil rolling and recruitment in P-selectin and intracellular adhesion molecule-1-deficient mice. Blood 1998; 91:2847-2856.
15. Broide DH. Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 2001; 108:S65-S71.
16. Rothenberg ME, MacLean JA, Pearlman E, et al. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 1997; 185:785-790.
17. Connell JT. Quantitative intranasal pollen challenges. II: The priming effect in allergic rhinitis. J Allergy 1969; 43:33-44.
18. Delespesse G, Sarfati M, Wu CY, et al. The low-affinity receptor for IgE. Immunol Rev 1992; 128:77-97.
19. Waldschmidt TJ, Tygrett LT. The low-affinity IgE receptor (CD23) participates in B cell activation. Adv Exp Med Biol 1992; 323:149-156.
20. Oettgen HC, Geha RS. IgE in asthma and atopy: cellular and molecular connections. J Clin Invest 1999; 104:829-835.
21. Yamaguchi M, Lantz CS, Oettgen HC, et al. IgE enhances mouse mast cell FcεRI expression in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997; 185:663-772.
22. Saini SS, MacGlashan DWJ, Sterbinsky SA, et al. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE infusions is reversible in vitro and in vivo. J Immunol 1999; 162:5624-5630.
23. Kisselgof AB, Oettgen HC. The expression of murine B cell CD23, in vivo, is regulated by its ligand, IgE. Int Immunol 1998; 10:1377-1384.
24. Päth G, Braumn A, Meents N, et al. Augmentation of allergic early-phase-reaction by nerve growth factor. Am J Respir Crit Care Med 2002; 166:818-826. This paper describes possible actions of NGF and its antagonization during early and late-phase response in allergic immediate reaction.
25. Cheung D, Van der Veen H, den Hartigh J, et al. Effects of inhaled substance P on airway responsiveness to methacholine in asthmatic subjects in vivo. J Appl Physiol 1994; 77:1326-1332.
26. Barnes PJ. Neuroeffector mechanisms: the interface between inflammation and neuronal responses. J Allergy Clin Immunol 1996; 98:S73-S81.
27. Lindsay RM, Hamar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337:362-364.
28. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992; 49:693-698.
29. Vedder H, Affolter HU, Otten U. Nerve growth factor (NGF) regulates tachykinin gene expression and biosynthesis in rat sensory neurons during early postnatal development. Neuropeptides 1993; 24:351-357.
30. Hunter DD, Myers AC, Undem BJ. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am J Respir Crit Care Med 2000; 161:1985-1990.
31. Levi-Montalcini R, Skaper D, Dal Toso R, et al. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996; 19:514-520.
32. Braun A, Appel E, Baruch R, et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998; 28:3240-3251.
33. Kimata H, Yoshida A, Ishioka C, et al. Nerve growth factor specifically induces human IgG4 production. Eur J Immunol 1991; 21:137-141.
34. Kimata H, Yoshida A, Ishioka C, Mikawa H. Stimulation of Ig production and growth of human lymphoblastoid B-cell lines by nerve growth factor. Immunology 1991; 72:452-455.
35. Brodie C, Gelfand EW. Regulation of immunoglobulin production by nerve growth factor: comparison with anti-CD40. J Neuroimmunol 1994; 52:87-96.
36. Oh SJ, Min YG, Kim JW, at al. Expression of nitric oxide synthases in nasal mucosa from a mouse model of allergic rhinitis. Ann Otol Rhinol Laryngol 2003; 112:899-903.
37. Benson M, Carlsson B, Carlsson LM, et al. Increased expression of vascular endothelial growth factor in seasonal allergic rhinitis. Cytokine 2002; 20:268-273. This paper demonstrates by an in-vivo study the role of VEGF-A as a new important mediator in seasonal allergic rhinitis.
38. Banwell ME, Robinson DS, Lloyd CM. Adenoid-derived TH2 cells reactive to allergen and recall antigen express CC chemokine receptor 4. J Allergy Clin Immunol 2003; 112:1155-1161. This paper demonstrates an important mechanism involved in the link between atopy and recurrent upper airways infections.
39. Amerio P, Frezzolini A, Feliciani C, et al. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr Drug Targets Inflamm Allergy 2003; 2:81-94. This paper discusses the role of eotaxins in a number of atopic conditions and speculates about possible therapeutic options.
40. Imai T, Yoshida T, Baba M, et al. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996; 271:21514-21521.
41. Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing TH2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11:81-88.
42. Sallusto F, Palermo B, Lenig D, et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999; 29:1617-1625.
43. Campbell JJ, Haraldsen G, Pan J, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 400:776-780.
44. Sekiya T, Miyamasu M, Imanishi M, et al. Inducible expression of a TH2-type CC chemokine. J Immunol 2000; 165:2205-2213.
45. Gear AR, Suttitanamongkol S, Viisoreanu D, et al. Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood 2001; 94:932-937.
46. Clemetson KJ, Clemetson JM, Proudfoot AE, et al. Functional expression of CCR1, CCR3, CCR4 and CXCR4 chemokine receptors on human platelets. Blood 2000; 94:4046-4054.
47. Sandoval-Lopez G, Teran LM. TARC: a novel mediator of allergic inflammation. Clin Exp Allergy 2001; 31:1809-1812.
48. Kawasaki S, Takizawa H, Yoneyama H, et al Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001; 166:1755-1764.
49. Scavuzzo MC, Rocchi V, Fattori B, et al. Cytokine secretion in nasal mucus of normal subjects and patients with allergic rhinitis. Biomed Pharmacother 2003; 57:366-371. This paper elicits the role of the Th2 cytokines IL-6 and IL-10 in allergic rhinitis.
50. Henry PJ, Mann TS, D'Aprile AC, et al. An endothelin receptor antagonist, SB-217242, inhibits airway hyperresponsiveness in allergic mice. Am J Physiol Lung Cell Mol Physiol 2002; 283:L1072-L1078.
51. Taube C, Duez C, Cui Z-H, et al. The role of IL-13 in established allergic airway disease. J Immunol 2002; 169:6482-6489. This paper elicits the role of IL-13 in the in-vivo setting of a mouse model.
52. Yoshikawa M, Matsumoto K, Iida M, et al. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis. Int Arch Allergy Immunol 2002; 128 (Suppl 1):3-11. This paper investigates which extracellular matrix proteins may be important for early and late-phase eosinophil chemotaxis.